InterCure Ltd.
85 Medinat ha-Yehudim Street
Herzliya 4676670
Israel
972 7 746 05012
https://www.intercure.co
版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工:
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Alexander Rabinovich | CEO & Director | 728k | 無 | 1971 |
| Mr. Amos Cohen | Chief Financial Officer | 1.13M | 無 | 1979 |
| Einat Zehavi | Vice President of Sales | 859k | 無 | 無 |
截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。
描述
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
公司管治
截至 無 止，InterCure Ltd. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
